NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
14,893,662
Share change
-180,523
Total reported value
$9,424,000
Put/Call ratio
688%
Price per share
$0.64
Number of holders
49
Value change
-$198,710
Number of buys
14
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q4 2016

As of 31 Dec 2016, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,893,662 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Harel Insurance Investments & Financial Services Ltd., MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Spark Investment Management LLC, BlackRock Fund Advisors, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.